PGEN — Precigen, Inc. stock price, charts and financials

QT62Precigen, Inc.

Precigen, Inc. (NASDAQ: PGEN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
6.53
-0.08-1.21%
PGENQT62Precigen, Inc.·NASDAQ
6.53-1.21%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Aug 04, 20268-KCurrent report
Aug 04, 202610-QQuarterly report
Aug 03, 20264Statement of changes in beneficial ownership
Jul 31, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 24, 20268-KCurrent report
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
May 27, 20264Statement of changes in beneficial ownership
May 27, 20264Statement of changes in beneficial ownership
May 27, 20264Statement of changes in beneficial ownership
May 27, 20264Statement of changes in beneficial ownership
May 27, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20268-KCurrent report
May 13, 202610-QQuarterly report
Apr 30, 2026DEFA14AAdditional proxy soliciting materials
Apr 30, 2026DEF 14ADefinitive proxy statement
Apr 30, 2026ARSAnnual report to shareholders
Apr 22, 20264Statement of changes in beneficial ownership